Hamilton J - Search Results

1

Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Davis S, Rafia R, Carroll C, Hamilton J, Essat M. Davis S, et al. Among authors: hamilton j. Pharmacoeconomics. 2019 Jun;37(6):763-775. doi: 10.1007/s40273-018-0727-1. Pharmacoeconomics. 2019. PMID: 30345464 Free article. Review.

2

Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Kearns B, Pandor A, Stevenson M, Hamilton J, Chambers D, Clowes M, Graham J, Kumar MS. Kearns B, et al. Among authors: hamilton j. Pharmacoeconomics. 2017 Apr;35(4):415-424. doi: 10.1007/s40273-016-0457-1. Pharmacoeconomics. 2017. PMID: 27770303 Free article. Review.

3

Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Carroll C, Tappenden P, Rafia R, Hamilton J, Chambers D, Clowes M, Durrington P, Qureshi N, Wierzbicki AS. Carroll C, et al. Among authors: hamilton j. Pharmacoeconomics. 2016 Nov 16. doi: 10.1007/s40273-016-0472-2. Online ahead of print. Pharmacoeconomics. 2016. PMID: 27848220 Review.

4

Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Carroll C, Tappenden P, Rafia R, Hamilton J, Chambers D, Clowes M, Durrington P, Qureshi N, Wierzbicki AS. Carroll C, et al. Among authors: hamilton j. Pharmacoeconomics. 2017 May;35(5):537-547. doi: 10.1007/s40273-017-0492-6. Pharmacoeconomics. 2017. PMID: 28285379 Free article. Review.

5

Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Bermejo I, Stevenson M, Cooper K, Harnan S, Hamilton J, Clowes M, Carroll C, Harrison T, Saha S. Bermejo I, et al. Among authors: hamilton j. Pharmacoeconomics. 2018 Feb;36(2):131-144. doi: 10.1007/s40273-017-0571-8. Pharmacoeconomics. 2018. PMID: 28933002 Free article. Review.

6

Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Pandor A, Stevenson M, Stevens J, James MM, Hamilton J, Byrne J, Rudin C, Rawdin A, Wong R. Pandor A, et al. Among authors: hamilton j. Pharmacoeconomics. 2018 Aug;36(8):903-915. doi: 10.1007/s40273-018-0627-4. Pharmacoeconomics. 2018. PMID: 29480454 Free article. Review.

7

Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Stevenson M, Pandor A, Hamilton J, Stevens J, Rowntree C, Martyn-St James M, Rawdin A, Wong R. Stevenson M, et al. Among authors: hamilton j. Pharmacoeconomics. 2018 Jul;36(7):759-768. doi: 10.1007/s40273-018-0624-7. Pharmacoeconomics. 2018. PMID: 29502175 Free article. Review.

8

Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Tappenden P, Simpson E, Hamilton J, Pollard D, Clowes M, Kaltenthaler E, Meiklejohn D, Morley N. Tappenden P, et al. Among authors: hamilton j. Pharmacoeconomics. 2019 Mar;37(3):333-343. doi: 10.1007/s40273-018-0713-7. Pharmacoeconomics. 2019. PMID: 30246228 Free article. Review.

9

Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.

Archer R, Hock E, Hamilton J, Stevens J, Essat M, Poku E, Clowes M, Pandor A, Stevenson M. Archer R, et al. Among authors: hamilton j. Health Technol Assess. 2018 Nov;22(66):1-294. doi: 10.3310/hta22660. Health Technol Assess. 2018. PMID: 30501821 Free PMC article.

10

Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model.

Tappenden P, Carroll C, Hamilton J, Kaltenthaler E, Wong R, Wadsley J, Moss L, Balasubramanian S. Tappenden P, et al. Among authors: hamilton j. Health Technol Assess. 2019 Feb;23(8):1-144. doi: 10.3310/hta23080. Health Technol Assess. 2019. PMID: 30821231 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,514 results

Search Page

Filters